Browsing Tag
Croda International Plc
2 posts
SkinBioTherapeutics (LSE: SBTX) is growing again, but will cash last long enough?
SkinBioTherapeutics is growing revenue, but cash and credibility remain tight. New FY2026 guidance will decide whether SBTX can rerate.
Croda shares rally 8.5% as Q3 sales rise 6.5%, fragrance and crop segments lead turnaround
Croda shares jump 8.5% on strong Q3 2025 results driven by fragrances, crop recovery, and margin focus. See what this means for investors heading into 2026.